NeoGenomics, Inc.

Good day, ladies and gentlemen, and welcome to the Neogenomics First Quarter 2020 Earnings Conference Call. All lines have been placed on the list in only mode, and the floor will be open for your questions and comments following the presentation. At this time, it is my pleasure to turn the floor over to your host for today, Mr. Doug Van Oort. Sir, the floor is yours.

Well, thank you, Jess, and good morning, everyone. I'd like to welcome everyone to Neogenomics First Quarter 2020 Conference Call. Joining me from our Fort Myers headquarters with social distancing precautions in place are Catherine McKenzie, our Chief Financial Officer, Rob Shovlin, President of our Clinical Division, and Bill Bonello, President of our Informatics Division and Director of Investor Relations. Joining the call via phone from locations across the country are George Cardoza, President of our Pharma Services Division, Dr. Larry Weiss, our Chief Medical Officer, and Doug Brown, our Chief Strategy and Corporate Development Officer. Before we begin our prepared remarks, Bill Bonello will read the standard language about forward-looking statements.

This conference call may contain forward-looking statements which represent our current expectations and beliefs about our operations, performance, financial condition and growth opportunities. Any statements made on this call that are not statements of historical fact are forward-looking statements. These statements by their nature involve substantial risk and uncertainties, certain of which are beyond our control. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual outcomes and results could differ materially from those indicated in the forward-looking statements. Any forward-looking statement speaks only as of today, and we undertake no obligation to update any such statements to reflect events or circumstances after today. Before turning the call back to Doug, I want to let everyone know that we will be making a copy of our prepared remarks for this morning's call, available in the investor relations section of our website shortly after the call is completed. We also want to let everyone know that we're going to limit the number of questions to two per person in order to give more people a chance to ask questions within the one hour that has been allocated for this call.